Biofourmis raises $35M to develop smarter treatments for chronic diseases
Biofourmis, a Singapore-based startup pioneering a distinctly tech-based approach to the treatment of chronic conditions, has raised a $35 million Series B round for expansion. The round was led by Sequoia India and MassMutual Ventures, the VC fund from Massachusetts...
Posted On 06 Jun 2019